
Jared Barsky
Examiner (ID: 7259, Phone: (571)272-2795 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1628 |
| Total Applications | 1117 |
| Issued Applications | 492 |
| Pending Applications | 146 |
| Abandoned Applications | 503 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8290437
[patent_doc_number] => 20120178757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'Method For The Prevention Of Cancer Metastasis'
[patent_app_type] => utility
[patent_app_number] => 13/314437
[patent_app_country] => US
[patent_app_date] => 2011-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 12066
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13314437
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/314437 | Method For The Prevention Of Cancer Metastasis | Dec 7, 2011 | Abandoned |
Array
(
[id] => 9015617
[patent_doc_number] => 20130230581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'EGFR ANTAGONIST FOR THE TREATMENT OF HEART DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/825605
[patent_app_country] => US
[patent_app_date] => 2011-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12400
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825605
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/825605 | EGFR ANTAGONIST FOR THE TREATMENT OF HEART DISEASE | Nov 29, 2011 | Abandoned |
Array
(
[id] => 8228474
[patent_doc_number] => 20120142684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'COMPOUNDS AND METHODS FOR SKIN REPAIR'
[patent_app_type] => utility
[patent_app_number] => 13/306637
[patent_app_country] => US
[patent_app_date] => 2011-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6864
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13306637
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/306637 | COMPOUNDS AND METHODS FOR SKIN REPAIR | Nov 28, 2011 | Abandoned |
Array
(
[id] => 8241041
[patent_doc_number] => 20120149775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'METHODS FOR PREVENTING AND IMPROVING SKIN ELASTIC PROPERTY LOSS'
[patent_app_type] => utility
[patent_app_number] => 13/306478
[patent_app_country] => US
[patent_app_date] => 2011-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5971
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13306478
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/306478 | METHODS FOR PREVENTING AND IMPROVING SKIN ELASTIC PROPERTY LOSS | Nov 28, 2011 | Abandoned |
Array
(
[id] => 9135573
[patent_doc_number] => 20130296288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'ORGANIC ELECTROLUMINESCENT DEVICE'
[patent_app_type] => utility
[patent_app_number] => 13/994766
[patent_app_country] => US
[patent_app_date] => 2011-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16660
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994766
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/994766 | ORGANIC ELECTROLUMINESCENT DEVICE | Nov 23, 2011 | Abandoned |
Array
(
[id] => 8186610
[patent_doc_number] => 20120115835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'METHODS FOR TREATMENT OF BACTERIAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 13/283406
[patent_app_country] => US
[patent_app_date] => 2011-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5822
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115835.pdf
[firstpage_image] =>[orig_patent_app_number] => 13283406
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/283406 | METHODS FOR TREATMENT OF BACTERIAL INFECTIONS | Oct 26, 2011 | Abandoned |
Array
(
[id] => 10174961
[patent_doc_number] => 09205149
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Pharmaceutical topical composition of mupirocin'
[patent_app_type] => utility
[patent_app_number] => 13/879008
[patent_app_country] => US
[patent_app_date] => 2011-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4703
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879008
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/879008 | Pharmaceutical topical composition of mupirocin | Oct 18, 2011 | Issued |
Array
(
[id] => 8186604
[patent_doc_number] => 20120115833
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'METHOD OF TREATING HEPATOCELLULAR CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 13/274363
[patent_app_country] => US
[patent_app_date] => 2011-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4779
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115833.pdf
[firstpage_image] =>[orig_patent_app_number] => 13274363
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/274363 | METHOD OF TREATING HEPATOCELLULAR CARCINOMA | Oct 16, 2011 | Abandoned |
Array
(
[id] => 8095741
[patent_doc_number] => 20120083471
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-05
[patent_title] => 'Novel Compounds, Pharmaceutical Compositions Containing Same, Methods of Use for Same, and Methods for Preparing Same'
[patent_app_type] => utility
[patent_app_number] => 13/273740
[patent_app_country] => US
[patent_app_date] => 2011-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 22951
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20120083471.pdf
[firstpage_image] =>[orig_patent_app_number] => 13273740
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/273740 | Novel Compounds, Pharmaceutical Compositions Containing Same, Methods of Use for Same, and Methods for Preparing Same | Oct 13, 2011 | Abandoned |
Array
(
[id] => 8228525
[patent_doc_number] => 20120142738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'Pharmaceutical composition for treating dermatological autoimmune diseases'
[patent_app_type] => utility
[patent_app_number] => 13/272750
[patent_app_country] => US
[patent_app_date] => 2011-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3093
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13272750
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/272750 | Pharmaceutical composition for treating dermatological autoimmune diseases | Oct 12, 2011 | Abandoned |
Array
(
[id] => 8228572
[patent_doc_number] => 20120142776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'METHODS AND COMPOSITIONS FOR INDUCING PHYSIOLOGICAL HYPERTROPHY'
[patent_app_type] => utility
[patent_app_number] => 13/272910
[patent_app_country] => US
[patent_app_date] => 2011-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 37302
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13272910
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/272910 | METHODS AND COMPOSITIONS FOR INDUCING PHYSIOLOGICAL HYPERTROPHY | Oct 12, 2011 | Abandoned |
Array
(
[id] => 9162153
[patent_doc_number] => 20130310431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'USES FOR SUBSTITUTED 2-AMINO-THIAZOLONES IN TREATING ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/879229
[patent_app_country] => US
[patent_app_date] => 2011-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4208
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13879229
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/879229 | USES FOR SUBSTITUTED 2-AMINO-THIAZOLONES IN TREATING ALZHEIMER'S DISEASE | Oct 10, 2011 | Abandoned |
Array
(
[id] => 8301971
[patent_doc_number] => 20120184522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'THERAPEUTIC APPLICATIONS IN THE CARDIOVASCULAR FIELD OF QUINAZOLINEDIONE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/268371
[patent_app_country] => US
[patent_app_date] => 2011-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35167
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13268371
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/268371 | Therapeutic applications in the cardiovascular field of quinazolinedione derivatives | Oct 6, 2011 | Issued |
Array
(
[id] => 8186655
[patent_doc_number] => 20120115846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'QUINAZOLINEDIONE DERIVATIVES, PREPARATION THEREOF AND VARIOUS THERAPEUTIC USES THEREOF.'
[patent_app_type] => utility
[patent_app_number] => 13/268164
[patent_app_country] => US
[patent_app_date] => 2011-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25540
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115846.pdf
[firstpage_image] =>[orig_patent_app_number] => 13268164
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/268164 | Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof | Oct 6, 2011 | Issued |
Array
(
[id] => 8056269
[patent_doc_number] => 20120077872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-29
[patent_title] => 'PRESERVATIVE-FREE PHARMACEUTICAL TETRAHYDROLIPSTATIN COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/251884
[patent_app_country] => US
[patent_app_date] => 2011-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1862
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20120077872.pdf
[firstpage_image] =>[orig_patent_app_number] => 13251884
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/251884 | PRESERVATIVE-FREE PHARMACEUTICAL TETRAHYDROLIPSTATIN COMPOSITIONS | Oct 2, 2011 | Abandoned |
Array
(
[id] => 8916854
[patent_doc_number] => 20130178479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'PHARMACEUTICAL COMBINATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/876021
[patent_app_country] => US
[patent_app_date] => 2011-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 19153
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876021
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/876021 | PHARMACEUTICAL COMBINATIONS | Oct 2, 2011 | Abandoned |
Array
(
[id] => 8043673
[patent_doc_number] => 20120071570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'NOVEL ACYL ACIDIC AMINO ACID ESTER'
[patent_app_type] => utility
[patent_app_number] => 13/239520
[patent_app_country] => US
[patent_app_date] => 2011-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9290
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071570.pdf
[firstpage_image] =>[orig_patent_app_number] => 13239520
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/239520 | Acyl acidic amino acid ester | Sep 21, 2011 | Issued |
Array
(
[id] => 8417695
[patent_doc_number] => 20120245195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'NOVEL MONOHYDRATE OF AZAADAMANTANE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/238239
[patent_app_country] => US
[patent_app_date] => 2011-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 18813
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13238239
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/238239 | Monohydrate of azaadamantane derivatives | Sep 20, 2011 | Issued |
Array
(
[id] => 8158475
[patent_doc_number] => 20120100162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'Cyclophosphamide in Combination with Immune Therapeutics'
[patent_app_type] => utility
[patent_app_number] => 13/232326
[patent_app_country] => US
[patent_app_date] => 2011-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8696
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20120100162.pdf
[firstpage_image] =>[orig_patent_app_number] => 13232326
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/232326 | Cyclophosphamide in combination with immune therapeutics | Sep 13, 2011 | Issued |
Array
(
[id] => 8290453
[patent_doc_number] => 20120178771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'Oral Pharmaceutical Compositions of Buprenorphine and Method of Use'
[patent_app_type] => utility
[patent_app_number] => 13/229505
[patent_app_country] => US
[patent_app_date] => 2011-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 195708
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13229505
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/229505 | Oral Pharmaceutical Compositions of Buprenorphine and Method of Use | Sep 8, 2011 | Abandoned |